Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells
- 31 March 2011
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 234 (1-2), 148-154
- https://doi.org/10.1016/j.jneuroim.2011.03.001
Abstract
No abstract availableKeywords
Funding Information
- Biogen Idec Austria
This publication has 24 references indexed in Scilit:
- Gender-Specific Expression of β1 Integrin of VLA-4 in Myelin Basic Protein-Primed T Cells: Implications for Gender Bias in Multiple SclerosisThe Journal of Immunology, 2010
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 casesThe Lancet Neurology, 2010
- β 1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunityProceedings of the National Academy of Sciences of the United States of America, 2009
- Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosisActa Neurologica Scandinavica, 2009
- Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2009
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to NatalizumabArchives of Neurology, 2008
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosisNeurology, 2008
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007
- The impact of interferon-β treatment on the blood–brain barrierDrug Discovery Today, 2006
- Involvement of JC Virus–Infected Mononuclear Cells from the Bone Marrow and Spleen in the Pathogenesis of Progressive Multifocal LeukoencephalopathyThe New England Journal of Medicine, 1988